君實生物(01877.HK):建議採納2020年A股限制性股票激勵計劃
格隆匯 9 月 30日丨君實生物(01877.HK)發佈公告,2020年9月29日,董事會(身為激勵計劃項下激勵對象的董事已棄權)同意建議採納本激勵計劃的決議案以及根據特別授權建議發行及授予激勵計劃項下新A股。建議激勵計劃須於臨時股東大會及類別股東大會上以特別決議案的方式獲股東批准後方可作實。公司或會應中國大陸及╱或中國香港監管機構的要求對激勵計劃作出修訂。公司建議根據該計劃向激勵對象(包括公司若干關連人士)授予A股。
本激勵計劃擬授出的限制性股票總數將不超過35,736,500股A股,佔該公告日期公司已發行A股總數約5.19%及已發行股本總額約4.10%,其中7,147,000股A股(佔激勵計劃項下限制性股票總數約20%)將予以預留在以後期間(應為採納激勵計劃後12個月內)預留授出。
本激勵計劃旨在(其中包括)建立及提升公司的長期激勵機制,吸引及挽留公司的核心員工,全面調動彼等的熱情及創造力,有效提升核心團隊的凝聚力以及公司的競爭力,調整股東、公司及核心員工的利益,使彼等關注公司的長期發展,確保實現公司的發展戰略及業務目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.